Dr. Jones will be recognized at the American Society for Bioethics and Humanities Conference in October.

In this article Dr. Campo-Engelstein examines the gender norms regarding sexuality and reproduction to show how they shape surgical advancements

New publication in the American Journal of Bioethics responding to the issues of collateral findings in research embedded in the clinical setting by arguing for community advisory boards.

Creating a dialogue between the SHAPE (arts, humanities and social sciences) and STEM (biomedical, science, engineering and technology) disciplines this hybrid conference brings together global and local perspectives on practice, in a community of trust.

Dr. Molldrem has previously published about the ethical and policy implications of MHS/CDR programs in The American Journal of Bioethics and Critical Public Health.

“In this article, we contend that laws and health policies governing access to gender-affirming care should not unjustly discriminate between cisgender and transgender and gender diverse (TGD) patients. To demonstrate this point, we discuss two interventions, testosterone therapy and chest surgery, that hold gender affirmation as a goal and share the qualities of being initiated by the patient and evaluated on psychosocial outcomes. Recognizing these as gender-affirming interventions can help identify forms of bias against TGD patients and the clinicians who care for them.”

The talk outlined the benefits and harms of posthumous assisted reproduction for various stakeholders, including the deceased, the deceased’s partner and family, and posthumously conceived children.

Gender-affirming care is almost exclusively discussed in connection with transgender medicine. However, this article argues that such care predominates among cisgender patients, people whose gender identity matches their sex assigned at birth.

Dr. Emma Tumilty and Dr. Jeff Farroni attended the Asia Pacific Bioethics Education Network Congress 2023 in Manila and presented at multiple events.

17th Annual International Conference on Clinical Ethics and Consultation, the conference theme “Clinical Ethics: Consultation and/or Education?”

In its ideal form, a contraceptive vaccine could prevent pregnancy without the messy side effects of some hormonal birth control.

The latest wave of research exploring the drugs focuses on conditions that disproportionately affect women. But amid claims ranging from poor-quality data to abuse, not everyone is celebrating this shift.

Sociologist Rene Almeling, bioethicist Lisa Campo-Engelstein, and physician-scientist Brian T. Nguyen are launching a book project designed to bring together a wide range of experts in the social sciences, humanities, public health, and medicine to rethink and reframe “male” reproductive and sexual health in the United States. The panel provided an overview of the many complexities facing those who work on issues such as contraception, infertility, “paternal effects” on reproductive outcomes, and the provision of reproductive and sexual healthcare.

What can we learn about the future of artificial intelligence by looking back fifty years to when molecular biologists were on the verge of creating artificial life? Bioethics & Health Humanities Assistant Professor Jacob Moses and Gili Vidan (Information Science, Cornell University) publish a perspective piece in the Washington Post about how recent calls for a moratorium on AI harken back to debates about the governance of biotechnology. To chart a responsible course forward for AI, science policymakers can learn lessons from the famous 1975 Asilomar conference on recombinant DNA.

Dr. Molldrem gave remarks arguing for a new paradigm in data ethics at a session of the Ethics and Real-World Evidence Research Project at NYU.